Praemium’s Ohanessian to leave firm

20 May 2021
| By Jassmyn |
image
image image
expand image

Praemium has announced its chief executive and board member, Michael Ohanessian, will be leaving the firm after almost a decade in the role effective immediately. 

In an announcement to the Australian Securities Exchange (ASX) the firm said non-executive director, Anthony Wamsteker, had immediately stepped into the interim CEO role. 

Praemium said Wamsteker would be paid a monthly fee of $50,000 for immediately assuming the role of executive director and interim CEO. 

The board had also appointed Deloitte Corporate Finance to undertake a strategic review of Praemium’s international business. 

The firm’s chair, Barry Lewin, said: “During his tenure, Michael has built a solid and profitable foundation at Praemium. He leaves the business having positioned Praemium for continued strong growth, both in Australia and overseas”. 

AUTHOR

Recommended for you

sub-bgsidebar subscription

Never miss the latest news and developments in wealth management industry

MARKET INSIGHTS

The succession dilemma is more than just a matter of commitments.This isn’t simply about younger vs. older advisers. It’...

1 month 3 weeks ago

Significant ethical issues there. If a relationship is in the process of breaking down then both parties are likely to b...

2 months 3 weeks ago

It's not licensees not putting them on, it's small businesses (that are licensed) that cannot afford to put them on. The...

2 months 4 weeks ago

ASIC has canceled the AFSL of Sydney-based asset consultant and research firm....

3 weeks 4 days ago

ASIC has banned a Melbourne-based financial adviser for eight years over false and misleading statements regarding clients’ superannuation investments....

1 week 6 days ago

ASIC has banned a Melbourne-based financial adviser who gave inappropriate advice to his clients including false and misleading Statements of Advice....

1 week 5 days ago

TOP PERFORMING FUNDS

ACS FIXED INT - AUSTRALIA/GLOBAL BOND
moneymanagement logo